The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma.
about
Tumor-platelet interaction in solid tumorsIncorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancerLaparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study.Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells.Prognosis and conditional disease-free survival among patients with ovarian cancerSignificance of platelet count in esophageal carcinomasRisk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients.Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancerPreoperative elevated platelet count and thrombocytosis in gynecologic malignancies.Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer.Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.
P2860
Q26853099-262208DD-AD2D-4D28-8FA8-ADBD4E85EF5CQ30975500-4CF44F31-B00A-4ACC-AD61-CCB19512F953Q33397995-197AB394-5E33-4988-AC87-A5AE475330C5Q34134501-8EBDB9F1-11B2-4FC7-96E7-51B0F63F3ABFQ34190753-4C463018-2AAF-42C9-91E0-576660DBA91CQ34692286-0D0EBAC7-F96B-42ED-93FE-125BBC483DCBQ34996025-424CECEF-68BD-4379-8CAE-794EDD264545Q35121862-3F0A6680-EFFA-4197-A42C-F95B43ED7398Q35176826-E794D748-2973-4A3B-BBA0-FF5C4FA83095Q35235675-1E23F6F7-DD13-4630-A641-B8AACB54A4EEQ37383301-72A6BD62-8CBC-4F15-99F9-C5728F3B5E17Q37459671-760593DC-AA5F-4467-A59B-FD9C3E14F944Q38813923-CE3374E8-9BA0-44F4-837E-FF0A6857ECE9Q41264576-4A7CCB49-20DC-423B-885D-795F2856B804Q49674385-BD237AB9-B6E9-4220-A708-4FFEF59A22D9
P2860
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The prediction of progression- ...... epithelial ovarian carcinoma.
@ast
The prediction of progression- ...... epithelial ovarian carcinoma.
@en
type
label
The prediction of progression- ...... epithelial ovarian carcinoma.
@ast
The prediction of progression- ...... epithelial ovarian carcinoma.
@en
prefLabel
The prediction of progression- ...... epithelial ovarian carcinoma.
@ast
The prediction of progression- ...... epithelial ovarian carcinoma.
@en
P2093
P2860
P1476
The prediction of progression- ...... epithelial ovarian carcinoma.
@en
P2093
A Baalbergen
A C Ansink
C G Gerestein
C W Burger
M E L van der Burg
M J C Eijkemans
R H M Dykgraaf
P2860
P304
P356
10.1111/J.1471-0528.2008.02033.X
P577
2009-02-01T00:00:00Z